2024-04-012025-03-312025-03-31false10493472LAYA HEALTHCARE LTD2025-12-22falseiso4217:GBPxbrli:pure104934722024-03-31104934722025-03-31104934722024-04-012025-03-31104934722023-03-31104934722024-03-31104934722023-04-012024-03-3110493472bus:SmallEntities2024-04-012025-03-3110493472bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110493472bus:FullAccounts2024-04-012025-03-3110493472bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110493472core:WithinOneYear2025-03-3110493472core:AfterOneYear2025-03-3110493472core:WithinOneYear2024-03-3110493472core:AfterOneYear2024-03-3110493472core:ShareCapital2025-03-3110493472core:SharePremium2025-03-3110493472core:RevaluationReserve2025-03-3110493472core:OtherReservesSubtotal2025-03-3110493472core:RetainedEarningsAccumulatedLosses2025-03-3110493472core:ShareCapital2024-03-3110493472core:SharePremium2024-03-3110493472core:RevaluationReserve2024-03-3110493472core:OtherReservesSubtotal2024-03-3110493472core:RetainedEarningsAccumulatedLosses2024-03-3110493472core:LandBuildings2025-03-3110493472core:PlantMachinery2025-03-3110493472core:Vehicles2025-03-3110493472core:FurnitureFittings2025-03-3110493472core:OfficeEquipment2025-03-3110493472core:NetGoodwill2025-03-3110493472core:IntangibleAssetsOtherThanGoodwill2025-03-3110493472core:ListedExchangeTraded2025-03-3110493472core:UnlistedNon-exchangeTraded2025-03-3110493472core:LandBuildings2024-03-3110493472core:PlantMachinery2024-03-3110493472core:Vehicles2024-03-3110493472core:FurnitureFittings2024-03-3110493472core:OfficeEquipment2024-03-3110493472core:NetGoodwill2024-03-3110493472core:IntangibleAssetsOtherThanGoodwill2024-03-3110493472core:ListedExchangeTraded2024-03-3110493472core:UnlistedNon-exchangeTraded2024-03-3110493472core:LandBuildings2024-04-012025-03-3110493472core:PlantMachinery2024-04-012025-03-3110493472core:Vehicles2024-04-012025-03-3110493472core:FurnitureFittings2024-04-012025-03-3110493472core:OfficeEquipment2024-04-012025-03-3110493472core:NetGoodwill2024-04-012025-03-3110493472core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110493472core:ListedExchangeTraded2024-04-012025-03-3110493472core:UnlistedNon-exchangeTraded2024-04-012025-03-3110493472core:MoreThanFiveYears2024-04-012025-03-3110493472core:Non-currentFinancialInstruments2025-03-3110493472core:Non-currentFinancialInstruments2024-03-3110493472dpl:CostSales2024-04-012025-03-3110493472dpl:DistributionCosts2024-04-012025-03-3110493472core:LandBuildings2024-04-012025-03-3110493472core:PlantMachinery2024-04-012025-03-3110493472core:Vehicles2024-04-012025-03-3110493472core:FurnitureFittings2024-04-012025-03-3110493472core:OfficeEquipment2024-04-012025-03-3110493472dpl:AdministrativeExpenses2024-04-012025-03-3110493472core:NetGoodwill2024-04-012025-03-3110493472core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110493472dpl:GroupUndertakings2024-04-012025-03-3110493472dpl:ParticipatingInterests2024-04-012025-03-3110493472dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110493472core:ListedExchangeTraded2024-04-012025-03-3110493472dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110493472core:UnlistedNon-exchangeTraded2024-04-012025-03-3110493472dpl:CostSales2023-04-012024-03-3110493472dpl:DistributionCosts2023-04-012024-03-3110493472core:LandBuildings2023-04-012024-03-3110493472core:PlantMachinery2023-04-012024-03-3110493472core:Vehicles2023-04-012024-03-3110493472core:FurnitureFittings2023-04-012024-03-3110493472core:OfficeEquipment2023-04-012024-03-3110493472dpl:AdministrativeExpenses2023-04-012024-03-3110493472core:NetGoodwill2023-04-012024-03-3110493472core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110493472dpl:GroupUndertakings2023-04-012024-03-3110493472dpl:ParticipatingInterests2023-04-012024-03-3110493472dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110493472core:ListedExchangeTraded2023-04-012024-03-3110493472dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110493472core:UnlistedNon-exchangeTraded2023-04-012024-03-3110493472core:NetGoodwill2025-03-3110493472core:IntangibleAssetsOtherThanGoodwill2025-03-3110493472core:LandBuildings2025-03-3110493472core:PlantMachinery2025-03-3110493472core:Vehicles2025-03-3110493472core:FurnitureFittings2025-03-3110493472core:OfficeEquipment2025-03-3110493472core:AfterOneYear2025-03-3110493472core:WithinOneYear2025-03-3110493472core:ListedExchangeTraded2025-03-3110493472core:UnlistedNon-exchangeTraded2025-03-3110493472core:ShareCapital2025-03-3110493472core:SharePremium2025-03-3110493472core:RevaluationReserve2025-03-3110493472core:OtherReservesSubtotal2025-03-3110493472core:RetainedEarningsAccumulatedLosses2025-03-3110493472core:NetGoodwill2024-03-3110493472core:IntangibleAssetsOtherThanGoodwill2024-03-3110493472core:LandBuildings2024-03-3110493472core:PlantMachinery2024-03-3110493472core:Vehicles2024-03-3110493472core:FurnitureFittings2024-03-3110493472core:OfficeEquipment2024-03-3110493472core:AfterOneYear2024-03-3110493472core:WithinOneYear2024-03-3110493472core:ListedExchangeTraded2024-03-3110493472core:UnlistedNon-exchangeTraded2024-03-3110493472core:ShareCapital2024-03-3110493472core:SharePremium2024-03-3110493472core:RevaluationReserve2024-03-3110493472core:OtherReservesSubtotal2024-03-3110493472core:RetainedEarningsAccumulatedLosses2024-03-3110493472core:NetGoodwill2023-03-3110493472core:IntangibleAssetsOtherThanGoodwill2023-03-3110493472core:LandBuildings2023-03-3110493472core:PlantMachinery2023-03-3110493472core:Vehicles2023-03-3110493472core:FurnitureFittings2023-03-3110493472core:OfficeEquipment2023-03-3110493472core:AfterOneYear2023-03-3110493472core:WithinOneYear2023-03-3110493472core:ListedExchangeTraded2023-03-3110493472core:UnlistedNon-exchangeTraded2023-03-3110493472core:ShareCapital2023-03-3110493472core:SharePremium2023-03-3110493472core:RevaluationReserve2023-03-3110493472core:OtherReservesSubtotal2023-03-3110493472core:RetainedEarningsAccumulatedLosses2023-03-3110493472core:AfterOneYear2024-04-012025-03-3110493472core:WithinOneYear2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110493472core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110493472core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110493472core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110493472core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110493472core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110493472bus:Director12024-04-012025-03-3110493472bus:Director22024-04-012025-03-31

LAYA HEALTHCARE LTD

Registered Number
10493472
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

LAYA HEALTHCARE LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

KARUPPAIAH, Karthik, Dr
SURENDRAN, Aarthi, Dr

Registered Address

1 The Drive
Bexley
DA5 3DH

Registered Number

10493472 (England and Wales)
LAYA HEALTHCARE LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets48,53274,119
Investments226,980108,030
275,512182,149
Current assets
Debtors228,08178,064
Cash at bank and on hand113,158230,453
341,239308,517
Creditors amounts falling due within one year3(63,516)(57,518)
Net current assets (liabilities)277,723250,999
Total assets less current liabilities553,235433,148
Creditors amounts falling due after one year4(64,713)(76,391)
Provisions for liabilities6(6,408)(12,621)
Net assets482,114344,136
Capital and reserves
Called up share capital100100
Profit and loss account482,014344,036
Shareholders' funds482,114344,136
The financial statements were approved and authorised for issue by the Board of Directors on 22 December 2025, and are signed on its behalf by:
KARUPPAIAH, Karthik, Dr
Director
Registered Company No. 10493472
LAYA HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2.Average number of employees

20252024
Average number of employees during the year22
3.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-4,634
Bank borrowings and overdrafts11,79711,797
Taxation and social security51,71941,087
Total63,51657,518
4.Creditors: amounts due after one year

2025

2024

££
Other creditors64,71376,391
Total64,71376,391
5.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts64,71376,391
6.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)6,40812,621
Total6,40812,621